MINA OZA: Open Payments
NPI 1003856063 · WHITE PLAINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 109 payments from 17 companies in 2025. Trend: 2023 $2,533 · 2024 $2,500 · 2025 $1,844
Food & beverage: $1,837Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $347 |
| Vanda Pharmaceuticals Inc. | 12 | $262 |
| Teva Pharmaceuticals USA, Inc. | 8 | $228 |
| Neurocrine BioSciences, Inc. | 12 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $166 |
| E.R. Squibb & Sons, L.L.C. | 14 | $146 |
| Janssen Pharmaceuticals, Inc | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $75 |
| Tris Pharma Inc | 3 | $63 |
Products named: VRAYLAR, HETLIOZ, INGREZZA, CAPLYTA, UZEDY, COBENFY, REXULTI, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
